What Lies Ahead for The Vaccine Industry?

  We’ve got to ‘fight our corner’ was the message from Novartis’ David McIntosh as he opened up the 2014 World Vaccine Congress Europe You opened the conference this morning with the claim that ‘we need to fight our corner’ in the vaccine industry. Is the vaccine industry in trouble?   The pharmaceutical industry is broadly divided into pharma products …

Michael Hanna Vaccinogen cancer vaccine prostate cancer

The Problem with Cancer Vaccines

  You can’t treat a heterogeneous disease with a homogeneous treatment. That was the takeaway message from Vaccinogen’s founder at the World Vaccines Congress Europe Vaccine Nation caught up with Michael Hanna, the founder of Vaccinogen and creator of autologous patient-specific tumour cell vaccine OncoVAX, to discuss why there have been so many high-profile cancer vaccine failures and how this has affected …

Building a Universal Flu Vaccine

  Developing a universal flu vaccine requires a two part strategy targeted at the surface of the flu virus and it’s unchanging core At Last week’s World Vaccine Congress 2014, Vaccine Nation sat down with professor Sarah Gilbertson from the University of Oxford to discuss her progress towards developing a universal vaccine. What strategy are you currently pursuing in search …

The Most Influential People in Vaccines

Vaccine Nation presents the 50 most influential people in vaccines Download the Most Influential People in Vaccines to find out: Has Bill Gates lost his top spot? Who are the 25 new entries? Which disease field has produced the most influential experts Over the last two months we asked you to vote for who you believe are the three most influential …

What impact will the Ebola outbreak have on vaccine development for other neglected tropical diseases?

The 2014 Ebola outbreak in West Africa has devastated communities, leaving over 1000 dead according to WHO. Although arguably largely unreported in mainstream media until it started spreading outside of Africa, there is now lots of action in the Ebola space from companies throughout the world. It is unfortunate that it has taken this long for Ebola to get so …

Bettina Klug, PEI: The Future of Genetic Modification in Vaccine Development

The vaccine industry is in a time where there is a lot to be excited about around new developments. However, these new approaches to vaccine development bring significant challenges in terms of bringing them to market. Earlier this year the VaccineNation team were able to sit down with Dr Bettina Klug, Scientific Administrator at the Paul-Ehrlich-Institut to understand her thought …

Vaccine Viewpoints in association with the World Vaccine Congress Europe 2014

Vaccine Viewpoints: in association with the World Vaccine Congress Europe 2014

 Hear from the leaders of the vaccine industry on current issues and future progression. Today’s leaders of the vaccine industry have come together to discuss the latest developments and challenges within their field. Gain a preview into the key areas of interest that circulate the world of vaccine developments, expressed in Vaccine Viewpoints, in association with the World Vaccine Congress …

Digital Health 2014 Market Survey released

Digital technology is set to transform the way that health-related issues are studied, diagnosed and managed. Already a huge industry in the United States, Europe has been somewhat slower on the uptake. However even in Europe digital health activities are starting to surge and a fully fledged industry is emerging. Things like clinical trials, medical adherence, data reporting and even …